When I was 16 years old, my father was diagnosed with diabetes. Though I was too young to understand all of the medical terms and implications of such a diagnosis, I did know English which gave me an advantage he did not have. So I would go to the hospital with my dad, and the first thing I would look for was Spanish language signage, literature, nurses and other staff who spoke Spanish. Even though I am bilingual, I wanted to make sure that if I was not able to come to the hospital with my dad, he would be able to navigate the hospital system by himself.  

Picture yourself after a long flight to a Spanish-speaking country. You’re in the airport, tired and hungry, desperately needing to find a restroom before trying to make your way to the right luggage carousel and transportation. But all the signs you see are in Spanish and you don’t speak or read the language.

Did you know that 38 percent of Latinos in Texas are uninsured, compared to only 13.5 percent of non-Hispanic whites? And of the 6.1 million uninsured Texans, more than half (3.3 million) are Hispanic?

The results of that can be seen in Latino health outcomes. We are much less likely to receive preventive care such as screenings for cancer, blood pressure, cholesterol, heart disease, sexually transmitted diseases, and diabetes. We are almost twice as likely to have diabetes than non-Hispanic whites.

Federal healthcare law changes dramatically impact how the industry—hospitals, health-insurance companies and pharmas—do business today. University Hospitals in Cleveland has been aggressively reaching out to the newly insured, predominantly Blacks and Latinos. University Hospital’s Case Medical Center’s Rainbow Babies & Children’s Hospital, known as UH Rainbow, is receiving a $12.8-million grant to implement a Physician Extension Team, which works to improve the healthcare of about 68,000 children on Medicaid with high rates of emergency-room visits.

Posted by: Ben Lillie

In her TEDWomen talk, Deborah Rhodes, a physician and researcher at the Mayo Clinic, describes a new technique for screening women for breast tumors, and how innovation can proceed by tailoring the test to individual characteristics — in the case of Rhodes’ MBI, based on the tissue density — and also about the politics that gets in the way of making those innovations.